Jared Wolff and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.

Topics covered in this episode include: - Tesaro buyout rumors and analysis - Keytruda's approval in decentralized tumors with MSI-H and DMMR biomarkers - Cyramza's positive data in bladder cancer - does it stack up against I/O?

To learn more about Datamonitor Healthcare and our offerings, visit: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare